Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells

عرض إصدارات أخرى (1)

Factors that regulate the induction of apoptosis of tumour cells are potential candidates for therapeutic intervention for the majority of cancers. Studying modifiers of apoptotic responses, such as members of the tumour necrosis factor receptor superfamily, may give clues as to how induction of apo...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Cross, N, Waterman, E, Jokonya, N, Fowles, A, Buckle, C, Phillips, J, Holen, I, Hamdy, F, Eaton, C
التنسيق:	Journal article
اللغة:	English
منشور في:	2008

مواد مشابهة

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells.
حسب: Cross, N, وآخرون
منشور في: (2008)

Imaging the effects of castration on bone turnover and hormone-independent prostate cancer colonization of bone.
حسب: Cross, N, وآخرون
منشور في: (2008)

Human bone marrow stromal cells protect prostate and breast cancer cells from TRAIL-induced apoptosis
حسب: Nyambo, R, وآخرون
منشور في: (2004)

The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.
حسب: Cross, N, وآخرون
منشور في: (2005)

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
حسب: Nyambo, R, وآخرون
منشور في: (2004)

Analysis of the functional role of ADAMTS enzymes in prostate cancer
حسب: Molokwu, C, وآخرون
منشور في: (2005)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
حسب: Waterman, E, وآخرون
منشور في: (2007)

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
حسب: Holen, I, وآخرون
منشور في: (2002)

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
حسب: Eaton, C, وآخرون
منشور في: (2004)

Expression pattern of the ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) proteinases in human prostate cancer celllines
حسب: Chandrasekharan, S, وآخرون
منشور في: (2003)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
حسب: Holen, I, وآخرون
منشور في: (2002)

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
حسب: Eaton, C, وآخرون
منشور في: (2004)

Human bone marrow stromal cell derived IGF signaling enhances PSA production as well as proliferation/survival of androgen sensitive prostate cancer cells in vitro
حسب: Papageorgiou, M, وآخرون
منشور في: (2005)

EZH2 promotes proliferation and invasiveness of prostate cancer cells.
حسب: Bryant, R, وآخرون
منشور في: (2007)

Evaluating the role of ADAMTS proteoglycanases and TIMP-3 in prostate cancer progression
حسب: Adeniji, O, وآخرون
منشور في: (2007)

TIMP-3 expression is regulated by androgen and TNF in prostate stromal and cancer cells
حسب: Adeniji, O, وآخرون
منشور في: (2008)

TIMP-3 expression in prostate stromal and tumour cells is regulated by androgen and TNF
حسب: Adeniji, O, وآخرون
منشور في: (2007)

The role of osteoprotegerin in breast and prostate cancer
حسب: Holen, I, وآخرون
منشور في: (2002)

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype.
حسب: Darby, S, وآخرون
منشور في: (2008)

OPG is a survival factor for breast- and prostate cancer cells in vitro
حسب: Holen, I, وآخرون
منشور في: (2002)

The polycomb group protein EZH2 is required for transcriptional repression of p21 and MMP7 in prostate cancer cells
حسب: Bryant, R, وآخرون
منشور في: (2007)

Trailing TRAIL Resistance: Novel Targets for TRAIL sensitization in Cancer cells
حسب: RACHANA eTRIVEDI, وآخرون
منشور في: (2015-04-01)

Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes.
حسب: Korie A Grayson, وآخرون
منشور في: (2021-01-01)

Qualitative and quantitative PSA mRNA detection in prostate cancer - A useful tool for the clinician?
حسب: Phillips, J, وآخرون
منشور في: (2007)

Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.
حسب: Mitchell, A, وآخرون
منشور في: (2013)

High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde
حسب: Lee Jae-Won, وآخرون
منشور في: (2011-04-01)

Bone marrow stromal cell-derived insulin-like growth factor (IGF) II enhances growth and survival of prostate cancer cells and potentiates androgen action
حسب: Cross, N, وآخرون
منشور في: (2007)

Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis
حسب: Oliver H. Voss, وآخرون
منشور في: (2021-03-01)

HIV induces TRAIL sensitivity in hepatocytes.
حسب: Challagundla K Babu, وآخرون
منشور في: (2009-01-01)

The emphysematous lung is abnormally sensitive to TRAIL-mediated apoptosis
حسب: Milot Julie, وآخرون
منشور في: (2011-08-01)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
حسب: Rehman, I, وآخرون
منشور في: (2008)

Differential sensitivity of normal osteoblast-like cells and osteosarcoma cells to TRAIL and an agonist antibody to TRAIL receptor-2
حسب: Locklin, R, وآخرون
منشور في: (2005)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
حسب: Glen, A, وآخرون
منشور في: (2008)

Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2.
حسب: Masakatsu Oishi, وآخرون
منشور في: (2013-01-01)

Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases
حسب: L.A. Braga-Silva, وآخرون
منشور في: (2009-08-01)

iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer.
حسب: Rehman, I, وآخرون
منشور في: (2012)

Diurnal variation of non-specular meteor trails
حسب: J. Hinrichs, وآخرون
منشور في: (2009-05-01)

Global variation of meteor trail plasma turbulence
حسب: L. P. Dyrud, وآخرون
منشور في: (2011-12-01)

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
حسب: Rehman, I, وآخرون
منشور في: (2004)

Trail without Catheter after Transurethral Resection of Prostate: Clamp It or Not?
حسب: Vikash Talreja, وآخرون
منشور في: (2016-01-01)